impact factor
logo
 

Letter

 

Safety of BNT162b2 mRNA COVID-19 vaccine in a cohort of elderly, immunocompromised patients with systemic vasculitis


1, 2, 3, 4, 5, 6, 7

 

  1. Rheumatology Department, IRCCS Policlinico S. Matteo Foundation, University of Pavia, and PhD in Experimental Medicine, University of Pavia, Italy. paolo.delvino01@universitadipavia.it
  2. Rheumatology Department, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Italy.
  3. Rheumatology Department, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Italy.
  4. Rheumatology Department, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Italy.
  5. Rheumatology Department, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Italy.
  6. Rheumatology Department, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Italy.
  7. Rheumatology Department, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Italy.

CER14912
Letter

Free to view
(click on article PDF icon to read the article)

PMID: 34528506 [PubMed]

Received: 18/06/2021
Accepted : 23/07/2021
In Press: 16/09/2021

Rheumatology Article